Caina Technology Co. Ltd. (301122) - Net Assets
Based on the latest financial reports, Caina Technology Co. Ltd. (301122) has net assets worth CN¥1.80 Billion CNY (≈ $262.74 Million USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥1.93 Billion ≈ $282.48 Million USD) and total liabilities (CN¥134.85 Million ≈ $19.73 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check how resilient are Caina Technology Co. Ltd.'s assets to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | CN¥1.80 Billion |
| % of Total Assets | 93.01% |
| Annual Growth Rate | 53.42% |
| 5-Year Change | 378.19% |
| 10-Year Change | N/A |
| Growth Volatility | 79.52 |
Caina Technology Co. Ltd. - Net Assets Trend (2017–2024)
This chart illustrates how Caina Technology Co. Ltd.'s net assets have evolved over time, based on quarterly financial data. Also explore 301122 current and non-current assets for the complete picture of this company's asset base.
Annual Net Assets for Caina Technology Co. Ltd. (2017–2024)
The table below shows the annual net assets of Caina Technology Co. Ltd. from 2017 to 2024. For live valuation and market cap data, see 301122 company net worth.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | CN¥1.81 Billion ≈ $265.51 Million |
+0.43% |
| 2023-12-31 | CN¥1.81 Billion ≈ $264.36 Million |
+4.05% |
| 2022-12-31 | CN¥1.74 Billion ≈ $254.08 Million |
+240.38% |
| 2021-12-31 | CN¥510.12 Million ≈ $74.65 Million |
+34.44% |
| 2020-12-31 | CN¥379.44 Million ≈ $55.52 Million |
+118.68% |
| 2019-12-31 | CN¥173.52 Million ≈ $25.39 Million |
+56.06% |
| 2018-12-31 | CN¥111.18 Million ≈ $16.27 Million |
+22.60% |
| 2017-12-31 | CN¥90.68 Million ≈ $13.27 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Caina Technology Co. Ltd.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 9500.9% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | CN¥477.63 Million | 26.38% |
| Common Stock | CN¥122.25 Million | 6.75% |
| Other Components | CN¥1.21 Billion | 66.87% |
| Total Equity | CN¥1.81 Billion | 100.00% |
Caina Technology Co. Ltd. Competitors by Market Cap
The table below lists competitors of Caina Technology Co. Ltd. ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Beijing Andawell Science & Technology Co Ltd Class A
SHE:300719
|
$570.67 Million |
|
Anhui Wanyi Science and Technology Co Ltd
SHG:688600
|
$570.86 Million |
|
Henan Taloph Pharmaceutical Stock Co Ltd
SHG:600222
|
$571.05 Million |
|
TSEC Corp
TW:6443
|
$571.11 Million |
|
Hume Industries Berhad
KLSE:5000
|
$570.58 Million |
|
Taekwang Ind
KO:003240
|
$570.36 Million |
|
Sunflag Iron And Steel Company Limited
NSE:SUNFLAG
|
$570.30 Million |
|
Qt Group Oyj
HE:QTCOM
|
$570.25 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Caina Technology Co. Ltd.'s equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 1,806,591,578 to 1,810,886,345, a change of 4,294,767 (0.2%).
- Net income of 53,093,766 contributed positively to equity growth.
- Dividend payments of 48,898,263 reduced retained earnings.
- Other comprehensive income decreased equity by 48,255,478.
- Other factors increased equity by 48,354,742.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | CN¥53.09 Million | +2.93% |
| Dividends Paid | CN¥48.90 Million | -2.7% |
| Other Comprehensive Income | CN¥-48.26 Million | -2.66% |
| Other Changes | CN¥48.35 Million | +2.67% |
| Total Change | CN¥- | 0.24% |
Book Value vs Market Value Analysis
This analysis compares Caina Technology Co. Ltd.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 2.18x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 27.44x to 2.18x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2017-12-31 | CN¥1.16 | CN¥31.90 | x |
| 2018-12-31 | CN¥1.43 | CN¥31.90 | x |
| 2019-12-31 | CN¥2.16 | CN¥31.90 | x |
| 2020-12-31 | CN¥4.37 | CN¥31.90 | x |
| 2021-12-31 | CN¥5.56 | CN¥31.90 | x |
| 2022-12-31 | CN¥18.88 | CN¥31.90 | x |
| 2023-12-31 | CN¥14.77 | CN¥31.90 | x |
| 2024-12-31 | CN¥14.67 | CN¥31.90 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Caina Technology Co. Ltd. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 2.93%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 13.69%
- • Asset Turnover: 0.20x
- • Equity Multiplier: 1.09x
- Recent ROE (2.93%) is below the historical average (16.40%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2017 | 13.88% | 13.53% | 0.46x | 2.24x | CN¥3.52 Million |
| 2018 | 18.44% | 14.30% | 0.54x | 2.40x | CN¥9.38 Million |
| 2019 | 18.63% | 17.83% | 0.63x | 1.65x | CN¥14.98 Million |
| 2020 | 36.11% | 27.13% | 1.06x | 1.25x | CN¥99.09 Million |
| 2021 | 25.62% | 29.56% | 0.72x | 1.20x | CN¥79.67 Million |
| 2022 | 9.32% | 34.77% | 0.25x | 1.06x | CN¥-11.77 Million |
| 2023 | 6.23% | 27.42% | 0.21x | 1.07x | CN¥-68.10 Million |
| 2024 | 2.93% | 13.69% | 0.20x | 1.09x | CN¥-127.99 Million |
Industry Comparison
This section compares Caina Technology Co. Ltd.'s net assets metrics with peer companies in the Medical Instruments & Supplies industry.
Industry Context
- Industry: Medical Instruments & Supplies
- Average net assets among peers: $2,873,914,557
- Average return on equity (ROE) among peers: 5.05%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Caina Technology Co. Ltd. (301122) | CN¥1.80 Billion | 13.88% | 0.08x | $570.64 Million |
| Beijing Centergate Technologies Holding Co Ltd (000931) | $1.89 Billion | 4.92% | 0.86x | $523.48 Million |
| Blue Sail Medical Co Ltd (002382) | $9.82 Billion | 17.91% | 0.74x | $1.10 Billion |
| Andon Health Co Ltd (002432) | $1.60 Billion | 4.16% | 0.21x | $5.00 Billion |
| Allmed Medical Products Co Ltd Class A (002950) | $742.08 Million | 26.74% | 1.36x | $1.28 Billion |
| Guangzhou Improve Med Instrument (300030) | $563.53 Million | 4.77% | 0.17x | $376.43 Million |
| QITIAN Technology Group Co Ltd (300061) | $2.47 Billion | -32.17% | 0.22x | $924.78 Million |
| Shanghai Tofflon Science Tech (300171) | $8.05 Billion | 2.41% | 0.62x | $1.47 Billion |
| Truking Technology Ltd (300358) | $2.32 Billion | 6.92% | 0.71x | $1.02 Billion |
| Jiangxi Sanxin Medtec Co Ltd (300453) | $718.02 Million | 8.59% | 0.60x | $770.09 Million |
| Shenyang Xingqi Pharmaceutical Co Ltd (300573) | $574.90 Million | 6.24% | 0.48x | $2.50 Billion |
About Caina Technology Co. Ltd.
Caina Technology Co., Ltd. engages in the research, development, production, and sale of plastic particles, needle holders, needle tubes, rubber plugs and other packaging materials. It offers disposable sterile safe self-destructing syringes, disposable insulin syringes, disposable sterile insulin pen needles, disposable sterile blood collection needles, and other sterile medical devices. Caina T… Read more